Return On Assets of Viridian Therapeutics, Inc.\DE from 31 Mar 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Viridian Therapeutics, Inc.\DE quarterly and annual Return On Assets in % history and change rate from 31 Mar 2015 to 30 Sep 2025.
  • Viridian Therapeutics, Inc.\DE Return On Assets for the quarter ending 30 Sep 2025 was -47%, a 14% decline year-over-year.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2024 was -40%, a 35% increase from 2023.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2023 was -61%, a 44% decline from 2022.
  • Viridian Therapeutics, Inc.\DE annual Return On Assets for 2022 was -42%, a 11% increase from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Viridian Therapeutics, Inc.\DE Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -47% -6% -14% 01 Jul 2025 30 Sep 2025
Q2 2025 -50% -5% -11% 01 Apr 2025 30 Jun 2025
Q1 2025 -45% +4% +7.8% 01 Jan 2025 31 Mar 2025
Q4 2024 -40% +22% +35% 01 Oct 2024 31 Dec 2024
Q3 2024 -41% +16% +28% 01 Jul 2024 30 Sep 2024
Q2 2024 -45% +4% +8.6% 01 Apr 2024 30 Jun 2024
Q1 2024 -48% 0% -0.64% 01 Jan 2024 31 Mar 2024
Q4 2023 -61% -19% -44% 01 Oct 2023 31 Dec 2023
Q3 2023 -58% -12% -27% 01 Jul 2023 30 Sep 2023
Q2 2023 -49% +1% +2.8% 01 Apr 2023 30 Jun 2023
Q1 2023 -48% 0% -0.86% 01 Jan 2023 31 Mar 2023
Q4 2022 -42% +5% +11% 01 Oct 2022 31 Dec 2022
Q3 2022 -45% +50% +52% 01 Jul 2022 30 Sep 2022
Q2 2022 -50% +81% +61% 01 Apr 2022 30 Jun 2022
Q1 2022 -48% +104% +68% 01 Jan 2022 31 Mar 2022
Q4 2021 -48% +139% +75% 01 Oct 2021 31 Dec 2021
Q3 2021 -95% -6% -7.2% 01 Jul 2021 30 Sep 2021
Q2 2021 -131% -30% -29% 01 Apr 2021 30 Jun 2021
Q1 2021 -151% -54% -55% 01 Jan 2021 31 Mar 2021
Q4 2020 -187% -90% -93% 01 Oct 2020 31 Dec 2020
Q3 2020 -89% -8% -10% 01 Jul 2020 30 Sep 2020
Q2 2020 -101% -37% -56% 01 Apr 2020 30 Jun 2020
Q1 2020 -98% -41% -72% 01 Jan 2020 31 Mar 2020
Q4 2019 -97% -55% -131% 01 Oct 2019 31 Dec 2019
Q3 2019 -81% -42% -109% 01 Jul 2019 30 Sep 2019
Q2 2019 -65% -27% -70% 01 Apr 2019 30 Jun 2019
Q1 2019 -57% -16% -39% 01 Jan 2019 31 Mar 2019
Q4 2018 -42% +9% +18% 01 Oct 2018 31 Dec 2018
Q3 2018 -39% +19% +34% 01 Jul 2018 30 Sep 2018
Q2 2018 -38% +32% +45% 01 Apr 2018 30 Jun 2018
Q1 2018 -41% +42% +51% 01 Jan 2018 31 Mar 2018
Q4 2017 -51% +81% +61% 01 Oct 2017 31 Dec 2017
Q3 2017 -58% +84% +59% 01 Jul 2017 30 Sep 2017
Q2 2017 -70% +42% +38% 01 Apr 2017 30 Jun 2017
Q1 2017 -83% +12% +13% 01 Jan 2017 31 Mar 2017
Q4 2016 -133% -52% -65% 01 Oct 2016 31 Dec 2016
Q3 2016 -142% -60% -73% 01 Jul 2016 30 Sep 2016
Q2 2016 -112% -33% -43% 01 Apr 2016 30 Jun 2016
Q1 2016 -96% -6% -7.1% 01 Jan 2016 31 Mar 2016
Q4 2015 -80% 01 Oct 2015 31 Dec 2015
Q3 2015 -82% 01 Jul 2015 30 Sep 2015
Q2 2015 -78% 01 Apr 2015 30 Jun 2015
Q1 2015 -89% 01 Jan 2015 31 Mar 2015

Viridian Therapeutics, Inc.\DE Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -40% +22% +35% 01 Jan 2024 31 Dec 2024
2023 -61% -19% -44% 01 Jan 2023 31 Dec 2023
2022 -42% +5% +11% 01 Jan 2022 31 Dec 2022
2021 -48% +139% +75% 01 Jan 2021 31 Dec 2021
2020 -187% -90% -93% 01 Jan 2020 31 Dec 2020
2019 -97% -55% -131% 01 Jan 2019 31 Dec 2019
2018 -42% +9% +18% 01 Jan 2018 31 Dec 2018
2017 -51% +81% +61% 01 Jan 2017 31 Dec 2017
2016 -133% -52% -65% 01 Jan 2016 31 Dec 2016
2015 -80% 01 Jan 2015 31 Dec 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.